Joseph Edelman
CEO at PERCEPTIVE ADVISORS LLC
Investor
Deal Bio
Awards
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (29)
Key Relationships
Announcement Date
Deal Value
Axis Therapeutics
Athenex
value n/a
6 dealmakers
Nuvation Bio
Baupost Group
£214m
13 dealmakers
FREENOME
T. Rowe Price Group
£126m
30 dealmakers
Poseida Therapeutics
Vivo Capital
£109m
12 dealmakers
Immatics Biotechnologies
Arya Sciences Acquisition Corp
£288m
73 dealmakers
Atea Pharmaceuticals
Ally Bridge Group
£175m
27 dealmakers
ARCHERDX
INVITAE
£1,127m
56 dealmakers
Cerevel Therapeutics
Ecor1 Capital
£1,002m
66 dealmakers
Kronos Bio
Perceptive Advisors
£118m
18 dealmakers
I-MAB
Hillhouse Capital Group
£315m
33 dealmakers
C4 Therapeutics
Rtw Investments
£119m
26 dealmakers
Panacea Acquisition Corp
£650m
34 dealmakers
Compass Pathways
Camden Partners Nexus
£64m
7 dealmakers
Thrive Earlier Detection Corp
Exact Sciences
£1,651m
ZYMERGEN
Baillie Gifford & Co
£230m
9 dealmakers
Day One Biopharmaceuticals
Ra Capital Management
£94m
11 dealmakers
ABSCI
Casdin Capital
£90m
SOMALOGIC
Janus Henderson Investors
£891m
63 dealmakers
Immuneering Corporation
£44m
14 dealmakers
Crossover Health
£121m
Icosavax
Sanofi Ventures
£71m
19 dealmakers
Affinia Therapeutics
£80m
15 dealmakers
HONOR
£273m
8 dealmakers
Twin Health
Lts Investments
£103m
10 dealmakers
Cincor Pharma
Bvf Partners
£104m
Endeavor Biomedicines
£74m
DNANEXUS
Northpond Ventures
£151m
Zenas Biopharma
Agent Capital
Onkure Therapeutics
Surveyor Capital
£43m